What are the doses of Lorazepam (Ativan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ativan (lorazepam) should be prescribed at doses of 0.5-1 mg orally four times a day as required, with a maximum of 4 mg in 24 hours, for patients with anxiety or agitation who are able to swallow. This dosage recommendation is based on the most recent and highest quality study available, which was published in 2020 in the BMJ 1.

Key Considerations

  • For elderly or debilitated patients, the dose should be reduced to 0.25-0.5 mg, with a maximum of 2 mg in 24 hours, to minimize the risk of adverse effects 1.
  • Oral tablets can be used sublingually, which may be beneficial for patients who have difficulty swallowing 1.
  • It is essential to use the lowest effective dose and for the shortest duration possible to minimize the risk of dependence and withdrawal symptoms.
  • Patients should be monitored closely for signs of overdose, such as excessive sedation, confusion, or respiratory depression.

Comparison with Other Evidence

While other studies, such as the 2016 palliative care guidelines published in the Journal of the National Comprehensive Cancer Network, discuss the use of lorazepam for refractory insomnia and delirium, the 2020 BMJ study provides the most up-to-date and specific guidance on Ativan dosing 1. Therefore, the recommendations from the 2020 BMJ study should be prioritized.

Clinical Implications

In clinical practice, it is crucial to individualize the dose of Ativan based on the patient's response and tolerance. Patients should be educated about the potential risks and benefits of Ativan, including the risk of dependence and withdrawal symptoms, and the importance of not stopping the medication abruptly. By following the recommended dosage guidelines and closely monitoring patients, clinicians can minimize the risks associated with Ativan use and optimize its therapeutic benefits.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION ... The usual range is 2 mg/day to 6 mg/day given in divided doses, the largest dose being taken before bedtime, but the daily dosage may vary from 1 mg/day to 10 mg/day For anxiety, most patients require an initial dose of 2 mg/day to 3 mg/day given twice daily or three times daily. For insomnia due to anxiety or transient situational stress, a single daily dose of 2 mg to 4 mg may be given, usually at bedtime. For elderly or debilitated patients, an initial dosage of 1 mg/day to 2 mg/day in divided doses is recommended, to be adjusted as needed and tolerated

The recommended Ativan (lorazepam) doses are:

  • Usual range: 2 mg/day to 6 mg/day
  • Anxiety: 2 mg/day to 3 mg/day
  • Insomnia: 2 mg to 4 mg
  • Elderly or debilitated patients: 1 mg/day to 2 mg/day 2

From the Research

Ativan Doses

  • The provided study 3 does not specifically mention Ativan doses, but rather compares the efficacy and tolerability of clonazepam with other benzodiazepines, including lorazepam (which is another name for Ativan) in patients with anxiety disorders.
  • The study 3 found that all benzodiazepine groups, including lorazepam, showed significant improvements in Clinical Global Impression-Severity Scale (CGI-S), Clinical Global Impression-Anxiety Scale (CGI-anxiety), and Clinical Global Impression-Sleep Scale (CGI-sleep) scores after six weeks of treatment.
  • However, the study 3 does not provide information on the specific doses of lorazepam (Ativan) used in the treatment of anxiety disorders.
  • There are no specific details on Ativan doses in the provided study 3, as it focuses on the comparison of clonazepam with other benzodiazepines, rather than the dosage of individual medications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic Study.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.